Background: Caspase-2 deficiency accelerates tumorigenesis in mice but the underlying mechanisms remain unclear. Results: Caspase-2 catalytic site C320 and S139 residue sustain G2/M checkpoint and inhibit transformation and NF-κB activation. Conclusion: Both residues are required for caspase-2 to suppress tumorigenesis in nude mice. Significance: These findings provide insight into tumor suppression at the crossroads of apoptosis, cell cycle checkpoint and NF-κB pathways.
tumor suppressor activity all contribute to malignant cell survival, transformation, and tumor development (1) (2) (3) (4) . Caspase-2, one of the first mammalian caspases discovered (5-7) and the most evolutionarily conserved of the caspases, has been shown to influence all of the tumorpromoting activities listed above (8) (9) (10) (11) (12) . Caspase-2 promotes apoptosis induced by diverse stimuli and in DNA damage-induced apoptosis, caspase-2 participates in the mitochondrial (intrinsic) pathway of cell death by cleaving Bid, a premitochondrial step to release cytochrome c and Smac/Diablo from mitochondria, which leads to activation of downstream caspase-3, -6, and -7 and the demise of the cell (13) (14) (15) (16) (17) (18) . Caspase-2 also promotes the death receptor (extrinsic) apoptotic pathway in response to DNA damage (19) (20) . In mitotic catastrophe apoptosis induced by DNA damage, caspase-2 acts at an apical step upstream of cytochrome c release (21) (22) (23) (24) . In the "Chk1-inhibited ATM/ATR-caspase-2" apoptotic pathway, caspase-2 is activated upon Chk1 inactivation, and induces apoptosis in coordination with activated ATM and ATR (25) . Biochemically, caspase-2 activation for apoptosis can be mediated by the protein complex called PIDDosome, consisting of PIDD, RAIDD, and caspase-2. In this PIDDosome, caspase-2 was activated by PIDD, and RAIDD served as a bridging molecule binding to both caspase-2 and PIDD (26) (27) .
There are conflicting results on the details of the role of caspase-2 in the NF-κB pathway. One study showed that caspase-2 activates NF-κB in a manner that is dependent on its CARD domain, but independent of its catalytic activity and RIP1 cleavage (28) , whereas another concluded that caspase-2 functions as an endogenous inhibitor of NF-κΒ-dependent cell survival by proteolytic cleavage of RIP1 (29) .
In addition to its influence on apoptosis and NF-κB activity, caspase-2 has a tumor suppressor function in mice. Loss of caspase-2 increases cellular resistance to apoptosis, facilitates cell transformation, and enhances the tumorigenic potential of MEFs transformed by the oncogenes E1A/HRas V12 (30) . These transformed caspase-2 KO MEF cells show accelerated tumor development in athymic nude mice, and a deficiency for caspase-2 in mice accelerates lymphomagenesis induced by oncogenic Myc in the Eu-Myc-driven mouse lymphoma model (30) .
Although the catalytic activity of caspase-2 is important for many of its functions, it is unclear whether it plays a role in tumor suppression. In addition, it is unclear if any other site of caspase-2 might be important for its tumor suppressing function. Here we provide evidence for the requirement of the catalytic site C320 and S139 residue on the tumor-suppressing function of caspase-2.
EXPERIMENTAL PROCEDURES
Cell culture -All cells were cultured in DMEM High Glucose with 10% FBS in a 37°C, 5% CO 2 incubator.
Generation of K-Ras-transformed and SV40-immortalized MEF cells -Retrovirus-mediated expression systems were utilized to create MEF cells that were immortalized by SV40, or with stable expression of oncogene K-RAS in SV40-immortalized MEFs. Briefly, Phoenix packaging cells (refer http://www.stanford.edu/group/nolan) at 50% -70% confluency were transfected with VSVG, Rev, Gag-Pol, and pBABE-Zeo-SV40 Large T or pBABE-puro-K-Ras plasmids at a ratio of 3:3:6:9 (µg), with addition to the cell culture of 500 µl jetPRIME TM transfection agent (Polyplustransfection Inc., New York, NY). Thirty-six hours after the transfection, the retroviral supernatants were harvested and the package cells were removed by filtration (0.45µm filter). The resulting fresh retroviral solution was used directly to infect the target caspase-2 KO ) and S139 mutant (Casp2 S139A ) caspase-2, at 50% confluency. Fortyeight hours after retroviral infection, MEF cells were selected with 3 µg/ml respective antibiotics and all surviving clones were pooled together for experiments.
MTT cell proliferation assay -The methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay was performed as previously described (31) with minor modifications. Briefly, 1x10 4 cells were seeded in 24-well plates (for 24 hrs), 12-well plates (for 48 hrs), 60 mm plates (for 72 hrs), or 100 mm plates (for 96 hrs), and cultured at 37°C in a 5% CO 2 incubator. At different time points, as indicated above, medium was removed and cells were incubated with 1 mg/ml MTT for 2 hrs. The solution was then removed and the converted dye in the solution was resolved with 1 ml acidic isopropanol. This dye solution was harvested by centrifugation at 13,000 rpm for five minutes. The resulting supernatants were measured for absorbance at 595 nm by using an iMarkTM microplate reader (BIO-RAD).
Trypan blue exclusion assay -1x10 4 cells were seeded and cultured as described for the MTT assay. Cells were harvested at different time points and stained with trypan blue dye. The viable cells (negative for trypan blue) were counted.
Clonogenic cell-survival assay -Two hundred cells were seeded in triplicate in 60 mm dishes. Six hours after seeding, cells were irradiated in an x-ray machine (Faxitron RX-650) with the indicated doses. After seven days, cell colonies were stained with crystal violet and manually counted under a microscope (a colony was defined as a cell cluster containing at least 50 cells).
Soft agar assay -Performed as previously described with some modifications (30) . Specifically, 2x10 4 cells were seeded in 60 mm dishes with 0.35% agar on top of 6% agar (prepared in DMEM with 10% FBS). After 21 days, cell colonies were stained with crystal violet and manually counted under a microscope.
Tumor growth in athymic nude micePerformed as previously described with some modifications (30) . Specifically, 1x10
WT /SV40/Ras, Casp2 KO /SV40/Ras, Casp2 C320A /SV40/Ras, and Casp2 S139A /SV40/Ras MEF cells were suspended in 100 µl PBS and injected, s.c., in the flanks of mice. To avoid variation in immune responses among individual mice, two cell lines expressing different variants (WT vs. KO; WT vs. C320A; WT vs. S139A; KO vs. C320A; KO vs. S139A; and C320A vs. S139A) were injected to the left and right flank of the 8-week-old male nude mice (Harlan Laboratories), respectively. These injections were repeated in at least two additional mice such that each cell line was injected at least 9 times into mice. In one set of the experiments, 100 µl PBS was injected into the flanks of the nude mice as negative controls. All animal work conformed to institutional guidelines of the University of Cincinnati Institutional Animal Care and Use Committee.
Preparation of cell-free protein extractsCells in culture were harvested, washed with 1x ice-cold PBS and resuspended in lysis buffer (0.02 M HEPES at pH 7.4, 0.15 M NaCl, 0.001 M EDTA, and 1% Nonidet P-40 (IGEPAL-CA-630) with a protease inhibitor cocktail tablet (one tablet in 10 ml of lysis buffer, Roche Diagnostics GmbH, Mannheim, Germany) and kept on ice for 30 minutes. After centrifugation at 14,000 x g at 4°C, the supernatant was collected and protein concentration was measured by the Bradford method (BIO-RAD). To make tumor tissue lysates, nude mice were euthanized at the termination of experiments (Day 14). Tumors were retrieved and washed with 1x ice-cold PBS. A portion of each tumor (about 5mm x 5 mm) was immediately excised and immersed in the same lysis buffer and sonicated on ice for 25 seconds. Supernatant after 14,000 x g centrifugation for 10 minutes were collected and protein concentrations were measured as described above.
Western blotting -Aliquots of extracts containing a total of 50 µg protein were separated on SDS-PAGE, transferred to a PVDF membrane (BIO-RAD). Following blocking with 5% milk/PBST, membranes were incubated with primary antibodies overnight at 4°C. After wash with PBST, membranes were incubated with HRPconjugated secondary antibodies for 1 hr at room temperature, developed with ECL (PerkinElmer Inc.), and exposed to X-Ray films (Phenix Research Products).
Caspase-3 activity assay -Cells were first harvested by centrifugation at 700 x g and then the pellets were washed with PBS twice and lysed in cell lysis buffer containing 10 mM Tris-HCl (pH 7.5), 10 mM NaH 2 PO 4 /NaHPO4 (pH 7.5), 130 mM NaCl, 1% Triton X-100, and 10 mM Na 4 P 2 O 7 on ice for 20 min. After centrifugation at 10,000 x g for 10 min, supernatants were collected and protein concentrations were measured by the Bradford method (BIO-RAD). 50 µg protein from each sample (adjusted to a volume of 25 µl using the lysis buffer) were mixed with 30 mM of substrate DEVD-AFC (BioVision, Mountain View, CA) in 25 µl 2x assay buffer (40 mM HEPES, pH=7.5, 20% glycerol). Fluorescence was measured at 400 nm excitation and 505 nm emission following 2 hrs of incubation. Caspase 3 activity was measured by quantifying the cleavage of the fluorogenic peptide and results were expressed as the percentage of activity over the controls.
Immunofluorescent detection of mitotic cellsFlow cytometry analysis of the mitotic marker phosphorylated histone H3 was performed on a FACSCalibur (BD Biosciences) using CellQuest software. Cells were harvested by trypsinization, washed with ice-cold PBS once, and fixed in 70% ETOH at -20 °C overnight. Approximately 1 x 10 6 cells were then washed once with ice-cold PBS and stained with 10 µg/ml fluoresceinisothiocyanate-conjugated antibody against phosphorylated histone H3 Ser 10 (Millipore #16-222, Temecula, CA) for 1 hr at room temperature in the dark, followed by propidium iodide (20 µg/ml in PBS with 0.1% Triton X-100) and treated with 100 µg/ml RNase on ice for 20 minutes.
Immunohistochemistry -Paraffin-embedded tissue sections (5µm thick) from harvested tumor samples were subjected to immunostaining. The tissue sections were deparaffinized in xylene substitute (Shandon Thermo Scientific) and rehydrated in progressively decreasing concentrations of 100%, 95% and 70% of ethanol. Slides were washed with 1 x PBS once and boiled in antigen retrieval buffer (10 mM citrate) for 5 minutes in the microwave oven. The slides were left cool for 15 minutes on the counter and then incubated in 3% H 2 O 2 in 100% methanol for 15 minutes. The sections were washed and incubated with 5% normal goat serum (Vector Laboratories, USA) in PBST (0.1% Triton X-100) for 1 hr at room temperature. Sections were incubated with primary antibodies or normal IgG as a negative control at 4°C overnight. The slides were rinsed with PBS and incubated with biotinylated secondary antibodies for 1hr at room temperature. Tissue sections were washed in PBS and incubated with ABC reagent (VECTASTAIN ® Elite ABC kit, Vector Laboratories) for 30 minutes at room temperature. Each section was subjected to DABsubstrate mixture (Sigma-Aldrich, MO, USA), and was then counterstained with hematoxylin. The sections were washed with tap water, dehydrated in progressively increasing concentrations of 70%, 95%, and 100% ethanol and mounted with xylenebased mounting medium. Slides were visualized using the Axioplan 2 imaging microscope (Carl Zeiss Lichtmicroskopie, Göttingen, Germany).
Statistical analysis of caspase-2 gene expression data in human cancers -Publicly available datasets were retrieved from the NCBI GEO database. The search for appropriate datasets was facilitated by using the academic version of Oncomine (http://www.oncomine.org/). Statistical analysis of gene expression was conducted using the R package. Significance of differential expression was set to p-value < 0.001 derived using t-test.
Statistical analysis -Except caspase-2 gene expression in human cancers, data were expressed as the means ± S. E. M and analyzed using twoway ANOVA, one-way ANOVA, and post hoc tests as appropriate by GraphPad Prism (GraphPad Software, Inc., La Jolla, CA, USA). Results were considered statistically significant at P<0.05.
Antibodies -For western blotting: Anticleaved caspase-3 (Cell Signaling #9661), p-IκBα (Cell Signaling, #2859), XIAP (BD Transduction Laboratories, #610762), cIAP2 (Cell Signaling, #4952), Bcl-xL (gift from Dr. John C. Reed at the Sanford Burnham Institute), and Actin (cell signaling, #3700). For mitotic cell staining: antiphospho-histone H3 (Ser10), clone 3H10, FITC conjugate (Millipore,#16-222). For immunohistochemistry:
NF-κB p65 (Cell Signaling #3034), Bcl-xL (Santa Cruz Biotechnology #sc-8392), cIAP2 (Santa Cruz #sc-7944).
RESULTS

Enhanced cell proliferation in SV40-and SV40/K-Ras-transformed MEF cells expressing
C320A and S139A mutant caspase-2 -Given that caspase-2 inhibits transformation by the oncogenic E1A/HRas V12 (30), we made stable cell lines by immortalization of caspase-2 (Casp2) KO MEFs with SV40 alone (Casp2/SV40), or followed by transformation with a retroviral construct expressing K-Ras (Casp2/SV40/Ras). The cell line in each case was reconstituted with stable expression of wild-type or C320 mutant caspase-2. These resulting cell lines are isogenic and expression levels of exogenous caspase-2 protein are similar to endogenous level so that the experimental results would be comparable. We next analyzed the growth properties of these MEFs by the MTT proliferation assay. Consistent with the enhanced proliferation of Casp2 KO MEFs transformed with E1A/HRas V12 (30), our Casp2 KO /SV40 and Casp2 KO /SV40/Ras cells had significantly enhanced proliferation rate compared to wild-type control MEFs (Fig. 1A & 1B) . Interestingly, caspase-2 catalytic-dead Casp2 MEFs, transformed singly by SV40 or doubly by SV40/Ras, also displayed an enhanced proliferation rate, as compared with the wild-type cells ( Fig. 1A & 1B) . These results indicate that caspase-2 suppresses overproliferation and this function requires the catalytic activity of caspase-2.
It is known that caspase-2 is subject to regulation by phosphorylation, and that phosphorylation at several serine residues results in suppression of caspase-2 activity and inhibition of apoptosis (20, 22, (32) (33) . We here identified a new serine residue, S139, in the prodomain of caspase-2 that regulates various functions of caspase-2 as presented below. When S139A-mutant caspase-2 (Casp2 S139A ) was stably expressed in Casp2 KO /SV40 and Casp2 KO /SV40/Ras MEFs, it made the cells gain significantly enhanced growth rate displayed by MTT assay (Fig. 1A and 1B), which was confirmed by trypan blue exclusion assay ( Fig. 1C  & 1D ). These results demonstrate that similar to the catalytic site, S139 is also required for caspase-2 to suppress undesirable overproliferation.
Enhanced clonogenic activity in Casp2 C320A /SV40 and Casp2 S139A /SV40 MEF cellsThe loss of proliferation inhibition in caspase-2 mutant MEFs prompted us to evaluate their ability to divide by clonogenic assay. DNA damaging agents activate caspase-2 and this requires the protein complex PIDDosome (8, 10, 27) . Therefore, the four Casp2/SV40 cell lines described above were irradiated with IR at various doses (2 -10 Gy) and their clonogenic ability over a period of seven days was examined. We found that, similar to Casp2 KO cells, which is known to have higher clonogenic property (30), cells expressing C320A or S139A mutant caspase-2 formed significantly more colonies than their wildtype counterparts at the same dose of IR starting at 4 Gy ( Fig. 2A) . This increase in colony formation was also observed in different clones of each cell line (not shown). This result indicates that catalytic site C320 and site S139 are needed for caspase-2 to suppress undesirable increase in cell division and keep the rate of cell division in check in response to DNA damage.
Increased anchorage-independent growth in Casp2 C320A /SV40/Ras and Casp2 S139A /SV40/Ras MEF cells -Given the observed loss of inhibition in proliferation and clonogenic capabilities in caspase-2 mutant MEF cells, we further investigated the impact of these two sites on cellular transformation by determining the capacity of the corresponding cell lines in anchorage-independent growth in soft agar. We found that, similar to Casp2 KO cells, known to have enhanced anchorage-independent growth on soft agar (30) , MEF cells expressing C320A or S139A mutant caspase-2 formed significantly more colonies in soft agar than the wild-type MEF cells, and even more than KO cells (Fig. 2B & 2C) . This result demonstrates that the catalytic site and S139 are indispensible for caspase-2 to suppress anchorage-independent growth and cellular transformation. It also indicates that both mutations appear to have a dominant negative effect in anchorage-independent growth. Casp2 C320A /SV40/Ras and Casp2 S139A /SV40/Ras MEF cells are highly tumorigenic in athymic nude mice -To further investigate the consequences of loss of inhibition in proliferation and transformation resulting from mutation in caspase-2 catalytic site and the site S139, we examined the tumorigenic property of these caspase-2 mutant cells in athymic immunedeficient mice. We subcutaneously injected 10 6 cells (KO, WT, C320A, or S139A) into the flanks of athymic nude mice. Around five days after the injections we started to observe growth of cell masses in mice injected with KO MEF cells, but no cell masses were noticeable for WT cells at the same time. Fourteen days after injection, we observed only a mild tumorigenic capability coming from the injected Casp2 WT /SV40/Ras cells, as noted by the growth of small cell mass, whereas Casp2 KO /SV40/Ras cells were significantly highly tumorigenic and formed larger cell masses ( Fig.  3A and 3B ), which was in agreement with the previous report (30) . Interestingly, in addition to KO cells, Casp2 C320A /SV40/Ras and Casp2 S139A /SV40/Ras MEF cells also started to form cell masses on day 5 after injection and formed large cell masses with the size similar or larger than those grown from KO cells on day 14 ( Fig. 3A and 3B ). It is of note that the experimental results remained the same when bilateral or unilateral tumors were involved (not shown). These results demonstrate that the two residues are required for caspase-2 to suppress tumor development in nude mice. /SV40/Ras MEF cells over wild-type Casp2 cells -NF-κB is a transcription factor important for many cellular processes, among which constitutive NF-κB activity is associated with cell tumorigenic activity (2) . It has been reported that caspase-2 is an endogenous inhibitor of NF-κB (29) . Thus, we examined the effect of caspase-2 on IR-induced activation of NF-κB. The four cell lines of Casp2/SV40/Ras were irradiated with x-ray (20 Gy), and harvested at various time points up to 2 hrs. Activation of NF-κB was assessed by western blot analysis using an antibody specific for IκBα phosphorylation at serine 32 (p-IκBα), a signal that induces IκBα degradation and subsequent NF-κB nuclear translocation and activation (2) . Consistent with caspase-2 being an endogenous inhibitor of NF-κB reported in (29), we observed a significant increase in IκBα phosphorylation in irradiated KO MEF cells, as compared with non-irradiated KO cells (Fig. 4A) . This was also in contrast to the WT cells where no significant increase in IκBα phosphorylation following irradiation was observed (Fig. 4A) . Interestingly, irradiated C320A and S139A cells also displayed an increase in IR-induced IκBα phosphorylation, and this increase was sustained for up to two hours following IR treatment (Fig. 4A) . In addition, an increase of p65 nuclear translocation was observed in caspase-2 KO and C320A and S139A mutant cell lines compared to WT cells (not shown). These results demonstrate that the catalytic site and S139 residue are responsible for caspase-2 to suppress DNA-damage-induced NF-κB activation. The ability of cancer cells to escape apoptosis and continue to proliferate is one of the fundamental mechanisms for cancer development. In addition, one of the mechanisms for NF-κB to promote cell survival is to suppress apoptosis. We evaluated sensitivity of caspase-2 MEF cell lines to apoptosis induced by irradiation (20 Gy). Wildtype cells displayed significant cleavage of caspase-3, an indicator of apoptosis, at 6 and 24 hrs following IR (Fig. 4B) . In contrast, there was less amount of caspase-3 cleavage in KO, C320A and S139A cells at 6 and 24 hrs post IR (Fig. 4B) . This reduced caspase-3 activation was further confirmed by the measurement of caspase-3 activity using cleavage of fluorogenic caspase-3 substrates (Fig. 4C) . These results indicate that wild-type caspase-2, in response to relatively high dose of ionizing radiation at 20 Gy, sensitize cells to apoptosis, which requires the catalytic C320 and S139 sites.
Caspase-2 impacts G2/M DNA-damage checkpoint in response to low-dose γ-irradiation -
In contrast to apoptotic sensitivity of wild-type caspase-2 cells to high dose of IR (20 Gy), when a lower dose of 3 Gy was used to irradiate the cells, no significant difference in apoptotic sensitivity was detected by caspase-3 cleavage and fluorescent caspase-3 substrate assays in all four cell lines up to 24 hrs following IR (Fig. 5A and 5B). This result indicates that following low dose of IR, caspase-2 does not sensitize cells to apoptosis, or at least not yet up to 24 hrs. Intrigued by this result and the rather important role of C320 and S139 in all of the above cellular functions and by guest on November 7, 2017 http://www.jbc.org/ Downloaded from tumorigenesis in nude mice, we investigated whether C320 or S139 could play a role in other cellular processes following DNA damage induction.
Although insufficient to trigger apoptosis, low dose of IR can activate DNA-damage cell cycle checkpoints and such checkpoints are anti-tumor mechanisms that halt progression of cells from one phase of the cell cycle to the next to allow the time for DNA repair and maintenance of genome stability. As a result, impaired DNA-damage checkpoint is intimately related to cancer development (3). Since caspase-2-deficient MEF cells were abnormal in cell cycle progression in responses to IR (30), we examined the integrity of the G2/M DNA-damage checkpoint which prevents mitotic entry by arresting cells at G2 phase following induction of DNA damage. At various time points following irradiation at 4 Gy, the aforementioned four cell lines were labeled with an antibody recognizing phosphorylated histone H3 at serine 10, a marker of mitotic cells (44) . As expected, there was an IR-induced arrest of the cells at G2 phase of cell cycle in all four cell lines 2 hrs following irradiation (Fig. 5C) , indicating that the caspase-2 does not affect the activation of G2/M checkpoint. However, at 6 hrs post IR, a higher percentage of mitotic cells (relative to non-irradiated cells of the same cell line) was observed in caspase-2-deficient cells (96%) than that in wild-type cells (64%) (Fig. 5C ), demonstrating that caspase-2-deficient cells failed to sustain G2/M checkpoint arrest for longer periods of time. This result revealed that wild-type caspase-2 has a role in sustaining the G2/M checkpoint by delaying cells with DNA damage from entering mitosis therefore allowing repair. Similar to caspase-2 deficiency, mutation in C320 or S139 of caspase-2 also rendered cells unable to sustain the G2/M checkpoint at 6 hrs post IR, with a mitotic percentage of 128% and 85%, respectively (Fig. 5C ). Collectively these data revealed a new function of caspase-2 in sustaining the G2/M DNA-damage checkpoint and this function requires its catalytic site C320 and S139 residue.
Tumors derived from Casp2 KO (37) . To understand if NF-κB activation and resistance to apoptosis are associated with the tumor development observed in our nude mouse model, we evaluated the phosphorylation of IκBα in cell-free protein extracts prepared from the tumor mass derived in nude mice by western blot analyses. We found that IκBα was constitutively phosphorylated and also with higher levels of expression in the tumor extracts derived from Casp2 KO /SV40/Ras, Casp2 C320A /SV40/Ras, and Casp2 S139A /SV40/Ras MEF cells, as compared to those derived from Casp2 WT /SV40/Ras cells ( Fig. 6A and 6B ). Candidate protein targets of NF-κB known to confer apoptotic resistance such as Bcl-xL, XIAP, and cIAP2 were also up-regulated in the cell masses derived from caspase-2 KO, C320 and S139 mutant MEF cell lines compared to WT controls ( Fig. 6A and 6B) . These results were complemented by upregulation of p65 subunit of NF-κB and the three anti-apoptotic proteins in KO, S139 and C320 samples by immunohistochemical analysis of paraffin-embedded tumor samples (Fig,  6C) . Consistent with the upregulation of these anti-apoptotic proteins, expression of active proapoptotic caspase-3 (cleaved caspase-3) was not detectable in tumor samples derived from caspase-2 KO and two point mutant cell lines, whereas readily detectable in wild-type samples (Fig. 6C) .
DISCUSSION
This study provides new insight into how caspase-2 suppresses cell proliferation, transformation and tumorigenesis at the crossroads of apoptosis, cell cycle checkpoint and NF-κB pathways. Based on the experimental data presented in this study, we propose the following working model. As a multifunctional protein, the catalytic site C320 and S139 residue are essential for caspase-2 to suppress cellular hyperproliferation and aberrant activation of NF-κB, prolong DNA-damage-induced G2/M checkpoint, and promote pro-apoptotic cell death. These functions together contribute to the role of caspase-2 in the suppression of tumor development induced by oncogenic K-Ras in nude mice. This model is supported by the findings summarized below. The aberrant NF-κB activity and the resultant up-regulation of anti-apoptotic NF-κB target proteins could contribute to the apoptotic resistance in caspase-2 KO, C320A and S139A mutant cells. In the same cell populations, the failure to sustain G2/M checkpoint to a longer period of time could accelerate cell transformation and tumorigenesis by allowing cells with damaged DNA and genome instability to escape cell cycle arrest and go through cell division. Resistance to apoptosis companying with uncontrollable cell division could promote growth of tumor mass in the nude mice. This working model is also supported by the knowledge that G2/M checkpoint defect promotes tumorigenesis (3) and that the close association of upregulation of such three anti-apoptotic proteins, Bcl-xL, XIAP, and cIAP2, with constitutive activation of NF-κB and resistance to apoptosis in a variety of human malignancies (45) (46) (47) (48) (49) (50) .
Although the role of caspase-2 catalytic activity is well established in cell death, whether it is also involved in anti-tumor function of caspase-2 was not determined (30) . This study provides the first indication for the requirement of catalytic site C320 for anti-tumor function of caspase-2. Furthermore, this study identified a new site S139 of caspase-2 that is also involved in anti-tumor function of caspase-2. Caspase-2 with a single mutation at C320 or S139 rendered cells unable to sustain G2/M checkpoint to a longer period of time and more resistant to apoptosis. Meanwhile they exhibited enhanced NF-κB activity and were highly tumorigenic in nude mice. Similar to C320 mutant caspase-2, S139 mutant caspase-2 loses its apoptotic function despite that C320 is still wild type. Based on this, we speculated that S139 site promotes the catalytic activity of caspase-2. Since this residue is a serine, it could be a putative site of phosphorylation and subject to post translational modification following DNA damage similar to other reported serine residues on caspase-2 (20, 22, (32) (33) . Although we do not know at this time if S139A MEF cells actually have genomic instability, the reported increase in genomic instability in caspase-2 KO MEFs compared with wild-type cells (30) warrants further examination of genomic instability in S139A MEF cells. Therefore, this study lays foundation for future investigation into the molecular mechanism underlying the two sites of caspae-2 in tumor suppression.
It is also noted in this study that mutations at the catalytic site and S139 of caspase-2 confer cells with enhanced cellular activities over caspase-2 KO cells in many of the functions that we analyzed in this study. This indicates traits of gain-of-function mutations in these two sites. How these mutations give rise to such gain-of-function phenotypes is yet to be investigated. We speculate that these mutations may change the conformation of caspase-2, leading to changes of the dynamics of caspase-2 to interact with other proteins and gain new ability to interact with certain proteins that wild-type caspase 2 would not interact with.
This study opens new avenues for further studies of the tumor-suppressing function of caspase-2. The primary cleavage target of caspase-2 in promoting DNA damage-induced apoptosis is Bid, which mediates activation of the mitochondrial pathway of apoptotic cell death. It is important to examine if the resistance to apoptosis in cells expressing the two mutant forms of caspase-2 proteins is due to a lack of or attenuated Bid cleavage. Furthermore, cleavage target(s) of caspase-2 that mediates NF-κB pathway needs to be investigated. Since the catalytic activity is required for NF-κB suppression, it is reasonable to postulate that the target(s) of caspase-2 in the regulation of NF-κB is a protein(s) that can be catalytically cleaved by caspase-2. Along this line, it was reported that caspase-2 cleavage of RIP1 resulted in NF-κB suppression, whereas downregulation of caspase-2 resulted in NF-κB activation (29) . Our findings that wild-type caspase-2 keeps NF-κB activity in check and at a low level is in agreement with the above report. However, another report showed that caspase-2, in forming a complex with TRAF2 and RIP1, activates NF-κB, which requires its caspase recruitment domain and is independent of its enzymatic activity and RIP1 cleavage (28) . This discrepancy could be due to different experimental conditions and cell types. Moreover, this study warrants identification of protein targets of caspase-2 that are responsible for mediating the G2/M DNA-damage checkpoint function of caspase-2. Identification of these proteins involved in caspase-2 tumor-suppressing function will provide insight towards understanding the mechanism of tumor suppression mediated by caspase-2 and the potential for developing agents capable of modulating the level and activity of caspase-2 for the suppression of malignant transformation and tumorigenesis.
In addition to having a tumor-suppressing function in mice, caspase-2 may also have an impact on tumor suppression in humans as suggested by the significant reduction in caspase-2 gene expression in multiple types of human malignancies. This possibility is also supported by the following studies. For instance, the human caspase-2 gene resides on chromosome 7q, which is frequently deleted in leukemia (51). In addition, caspase-2 can be activated by cyclin D3 (52), upregulated by the candidate tumor suppressor RBM5 (53), and is linked to Mdm2 and the tumor suppressor p53 (30, (54) (55) (56) (57) . Furthermore, a portion of caspase-2 in human tumor cell lines is localized to the promyelocytic leukemia nuclear bodies (PML-NBs) (58), a subnuclear structure associated with apoptosis and the maintenance of genome stability, and also to the centrosome (59), the organelle that ensures the fidelity of cell division. Future work will need to address whether caspase-2 has a tumor suppressor function in humans and if there are somatic mutations at C320 and S139 and other sites of caspase-2 that are linked with human cancers.
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